FRIDAY, Sept. 23, 2022 (HealthDay News) — People with a rare genetic form of ALS may benefit from extended use of an investigational drug, a new study shows. The medication, tofersen, benefited patients with mutations of the gene SOD1. These mutations create a misfolded version of a protein, which leadsContinue Reading

FRIDAY, Sept. 16, 2022 (HealthDay News) — COVID-19 infection may significantly boost an older person’s risk of developing Alzheimer’s disease, a new, large-scale study suggests. People 65 and older who contracted COVID were nearly 70% more likely overall to be diagnosed with Alzheimer’s within a year of their infection, researchersContinue Reading

FRIDAY, Sept. 16, 2022 (HealthDay News) — While adults typically need steroid medication to treat Bell’s palsy, most children can recover without treatment, a new study finds. Bell’s palsy temporarily causes weakness and paralysis in facial muscles, making half of the face droop. The study — a randomized controlled trialContinue Reading